Course Overview

> The aim of this course is:

- To understand how to evaluate the effects of medicines and
therapeutic interventions both during drug development and clinical
use.
- To know the main methodological and ethical characteristics and
limitations of randomized clinical trials.
- To understand the differences between efficacy and effectiveness.
- To know the basic concepts and classification of the
pharmacoepidemiological studies designed to evaluate therapeutic
interventions.
- To identify information gaps in selectedtherapeutic areas (e.g.
cardiovascular, psychiatry, diabetes care).

Learning Achievement

Competence

Course prerequisites

- Post-graduated leve in Health or Life Sciences.
- Language prerequisites: Non-native English speakers must provide a
certificate proving a minimum of English B2 level (cf. Europass
[http://europass.cedefop.europa.eu/]).
- Computer and internet requirement.

Grading Philosophy

- Assessment is a mix of continuous assessment.
- Final assessment takes place by videoconference.

Course schedule

> This course consists of the following parts:

- Patients, medicines and prescribing in society. Life cycle of
medicines.
- The knowledge-building process of the effects and adverse effects
of medicines during their development and clinical use.
- Overview of studies to detect and to evaluate the risk associated
with therapeutic interventions. Scope, uses and limitations.
- The need to monitor the medicines prescribing process.
- Introduction to the study of the use ofmedicines in clinical
practice.

Course type

Recorded and live lectures, readings, home assignments, on-line quizzes, forums, wikis, live seminars.

Online Course Requirement

Instructor

Other information

- Professionals: 3,000€/year.
- Students: 1,500€/year.
- No additional costs and no mobility required.

Duration: 12 weeks

Language of instruction: English
Mode of delivery: E-learning

Site for Inquiry